Teva Pharmaceutical to Present at Three Major Investor Conferences in September
TEL AVIV, Israel, Sept. 01, 2026 /CourierPR/ -- Teva Pharmaceutical Industries, a leading biopharmaceutical company, is set to present at three major investor conferences in September 2026, according to a recent announcement.
Richard Francis, President and CEO of Teva, will participate in the following events: - Morgan Stanley 24th Annual Global Healthcare Conference: Scheduled for Monday, September 14, 2026, at 8:30 A.M. Eastern Time (ET). - J.P. Morgan U.S. All Stars Conference: Set for Tuesday, September 22, 2026, at 8:00 A.M. British Summer Time (3:00 A.M. ET). - BofA Global Healthcare Conference 2026: Taking place on Wednesday, September 23, 2026, at 10:55 A.M. British Summer Time (5:55 A.M. ET).
Teva Pharmaceutical Industries, founded over 120 years ago, is dedicated to improving health through innovative biopharmaceuticals. The company is expanding its presence in the fields of neuroscience and immunology, while also offering complex generic medicines, biosimilars, and pharmacy brands worldwide. Teva’s commitment to bettering health and addressing patient needs is evident through its strategic focus on growth and innovation.
The presentations will provide insights into Teva's strategic direction, including its pivot to growth strategy, which aims to expand its innovative and biosimilar medicines pipeline, sustain and focus its portfolio of generic medicines, and achieve cost savings through organizational transformation. Teva is committed to maintaining transparency with investors and stakeholders, as highlighted by the release of forward-looking statements.
It is important to note that these statements are subject to substantial risks and uncertainties, including market competition, regulatory compliance, and financial risks. Detailed information on these risks can be found in Teva’s recent filings, including the Quarterly Report on Form 10-Q for the second quarter of 2026 and the Annual Report on Form 10-K for the year ended December 31, 2025.